MedTrace Logo

Ventilator Adapters for Combivent Respimat

NCT01969539 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-02-10

Study results available
· View outcomes & findings →

Summary

The general aim of this 1-day, open label, non-randomised, trial is to characterize the performance of two adapter devices designed to permit use of the Respimat® inhaler with patients requiring mechanical ventilation.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Combivent Respimat via tee adapter

Patients (all); previously intubated and ventilated; in need of bronchodilation w/CVT-R via tee adapter

DRUG

Combivent Respimat via ventilator adapter

Patients (all); previously intubated and ventilated; in need of bronchodilation w/CVT-R via ventilator adapter

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-14
Primary Completion
2014-11-20
Completion
2014-11-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01969539 on ClinicalTrials.gov